Wolverine Trading
IRON icon

Wolverine Trading’s Disc Medicine IRON Stock Holding History

Wolverine Trading’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-710
Closed -$32K – 4477
2022
Q3 		$32K Buy
+710
New +$33.5K ﹤0.01% 4280

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Wolverine Trading's IRON Position: Q4 2022 in Review

Wolverine Trading sold out of Disc Medicine (IRON) in Q4 2022, closing a stake of 534 shares — an estimated $24K sold.

Wolverine Trading first reported a position in IRON in Q3 2022 and held it in 1 quarter. The position peaked at $24K in Q3 2022. 35 funds tracked by Wall St. Rank hold IRON as of Q4 2022.

  • Wolverine Trading reported no remaining Disc Medicine position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 534 Disc Medicine shares in Q4 2022, an estimated $24K.
  • Wolverine Trading first reported a position in Disc Medicine in Q3 2022 and held it in 1 quarter.
  • Wolverine Trading's Disc Medicine position peaked at $24K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.